Skip to content

Performance of Bausch & Lomb ReNu MultiPlus Multi-Purpose Solution in a New Packaging Configuration

Performance of Bausch & Lomb ReNu MultiPlus Multi-Purpose Solution in a Clear Polyethylene Terephthalate (PET) Bottle.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00659815
Enrollment
312
Registered
2008-04-16
Start date
2008-03-31
Completion date
2008-05-31
Last updated
2011-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comfort

Brief summary

The objective of the study is to evaluate the product performance of Bausch & Lomb ReNu MultiPlus Multi-Purpose Solution in a new packaging configuration

Interventions

DEVICEBausch & Lomb ReNu MultiPlus Multi-Purpose Solution Packaged in the Currently Marketed Resin Bottle.

Daily care for contact lenses.

DEVICEBausch & Lomb ReNu MultiPlus Multi-Purpose Solution Packaged in a Clear Resin Bottle.

Daily care for contact lenses

Sponsors

Bausch & Lomb Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject is a habitual wearer of planned replacement soft contact lenses * VA correctable to 0.3 LogMar or better (driving vision) * Clear central cornea * Subject uses a lens care system on a regular basis

Exclusion criteria

* Systemic disease affecting ocular health * Using systemic or topical medications * Wear monovision, multifocal or toric contact lenses * Any grade 2 or greater slit lamp findings

Design outcomes

Primary

MeasureTime frameDescription
ComfortOver-all follow-up visits from baseline to 1 monthNon-inferiority assessment of symptoms/complaints to rate solution comfort. Measurement based on 0-100 scale for each eye. Zero represented the least favorable rating and 100 represented the most favorable rating.
Slit Lamp FindingsOver-all follow-up visits from baseline to1 monthGraded 0-4 where Grade 0=none; Grade 1=Trace; Grade 2=Mild; Grade 3=Moderate; Grade 4=Severe.
Lens DepositsOver-all study visits, baseline to 1-monthLens Deposits (All Eligible, Dispensed Eyes) Absent = deposit ratings of none or light; Present = deposit ratings of medium or heavy.

Countries

United States

Participant flow

Recruitment details

This study was conducted in 23 investigative sites in the United States. First participant was enrolled 3/19/2008, last participant exited the study 5/19/08.

Pre-assignment details

312 Participants were enrolled, 2 participants were ineligible at baseline but were dispensed lens care solution and completed the study. 2 participants were not dispensed lens care solution. 308 eligible subjects started the study, 8 were discontinued during the study. 300 participants completed the study.

Participants by arm

ArmCount
Marketed Bottle ReNu MultiPlus Multi-Purpose Solution
Currently Marketed high-density polyethylene (HDPE) Bottle with B&L ReNu MultiPlus Multi-Purpose Solution for 1 month, daily contact lens care.
157
Clear Bottle ReNu MultiPlus Multi-Purpose Solution
Clear polyethylene terephthalate (PET) Bottle with B&L ReNu MultiPlus Multi-Purpose Solution for 1 month daily contact lens care.
151
Total308

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyInability to maintain wearing schedule12
Overall StudyStudy related symptoms and complaints21
Overall StudyWithdrawal by Subject11

Baseline characteristics

CharacteristicTotalClear Bottle ReNu MultiPlus Multi-Purpose SolutionMarketed Bottle ReNu MultiPlus Multi-Purpose Solution
Age, Customized
>=18 and <=65 years
308 Participants151 Participants157 Participants
Race/Ethnicity, Customized
American Indian or Alaska Native
1 Participants1 Participants0 Participants
Race/Ethnicity, Customized
Asian
15 Participants7 Participants8 Participants
Race/Ethnicity, Customized
Black or African American
9 Participants6 Participants3 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
3 Participants1 Participants2 Participants
Race/Ethnicity, Customized
White
280 Participants136 Participants144 Participants
Region of Enrollment
United States
308 participants151 participants157 participants
Sex: Female, Male
Female
230 Participants111 Participants119 Participants
Sex: Female, Male
Male
78 Participants40 Participants38 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1570 / 151
serious
Total, serious adverse events
0 / 1570 / 151

Outcome results

Primary

Comfort

Non-inferiority assessment of symptoms/complaints to rate solution comfort. Measurement based on 0-100 scale for each eye. Zero represented the least favorable rating and 100 represented the most favorable rating.

Time frame: Over-all follow-up visits from baseline to 1 month

Population: Symptoms/Complaints Over-All Scheduled Follow-Up Visits (All Eligible, Dispensed Eyes with non-missing scores)

ArmMeasureGroupValue (MEAN)Dispersion
Marketed Bottle ReNu MultiPlus Multi-Purpose SolutionComfortComfort90.2 Units on a ScaleStandard Deviation 12.7
Marketed Bottle ReNu MultiPlus Multi-Purpose SolutionComfortEnd of Day Comfort84.5 Units on a ScaleStandard Deviation 16.9
Marketed Bottle ReNu MultiPlus Multi-Purpose SolutionComfortBurning/Stinging on Insertion90.3 Units on a ScaleStandard Deviation 15.8
Marketed Bottle ReNu MultiPlus Multi-Purpose SolutionComfortIrritation90.2 Units on a ScaleStandard Deviation 14.1
Marketed Bottle ReNu MultiPlus Multi-Purpose SolutionComfortItching93.0 Units on a ScaleStandard Deviation 10.7
Marketed Bottle ReNu MultiPlus Multi-Purpose SolutionComfortDryness88.8 Units on a ScaleStandard Deviation 14.4
Marketed Bottle ReNu MultiPlus Multi-Purpose SolutionComfortRedness93.4 Units on a ScaleStandard Deviation 11.8
Marketed Bottle ReNu MultiPlus Multi-Purpose SolutionComfortVision93.5 Units on a ScaleStandard Deviation 12.4
Marketed Bottle ReNu MultiPlus Multi-Purpose SolutionComfortLens Cleanliness92.7 Units on a ScaleStandard Deviation 12.4
Marketed Bottle ReNu MultiPlus Multi-Purpose SolutionComfortLens Handling96.7 Units on a ScaleStandard Deviation 7.3
Clear Bottle ReNu MultiPlus Multi-Purpose SolutionComfortVision95.7 Units on a ScaleStandard Deviation 7.8
Clear Bottle ReNu MultiPlus Multi-Purpose SolutionComfortComfort92.7 Units on a ScaleStandard Deviation 9.3
Clear Bottle ReNu MultiPlus Multi-Purpose SolutionComfortDryness90.5 Units on a ScaleStandard Deviation 11.8
Clear Bottle ReNu MultiPlus Multi-Purpose SolutionComfortEnd of Day Comfort87.2 Units on a ScaleStandard Deviation 14.5
Clear Bottle ReNu MultiPlus Multi-Purpose SolutionComfortLens Handling95.3 Units on a ScaleStandard Deviation 10.3
Clear Bottle ReNu MultiPlus Multi-Purpose SolutionComfortBurning/Stinging on Insertion93.2 Units on a ScaleStandard Deviation 13.9
Clear Bottle ReNu MultiPlus Multi-Purpose SolutionComfortRedness94.0 Units on a ScaleStandard Deviation 11.2
Clear Bottle ReNu MultiPlus Multi-Purpose SolutionComfortIrritation92.9 Units on a ScaleStandard Deviation 10.6
Clear Bottle ReNu MultiPlus Multi-Purpose SolutionComfortLens Cleanliness92.7 Units on a ScaleStandard Deviation 12.4
Clear Bottle ReNu MultiPlus Multi-Purpose SolutionComfortItching94.9 Units on a ScaleStandard Deviation 9.3
Primary

Lens Deposits

Lens Deposits (All Eligible, Dispensed Eyes) Absent = deposit ratings of none or light; Present = deposit ratings of medium or heavy.

Time frame: Over-all study visits, baseline to 1-month

Population: Lens deposits over all scheduled follow-up visits (all eligible, dispensed eyes with non-missing data)

ArmMeasureGroupValue (NUMBER)
Marketed Bottle ReNu MultiPlus Multi-Purpose SolutionLens DepositsAbsent292 Eyes
Marketed Bottle ReNu MultiPlus Multi-Purpose SolutionLens DepositsPresent18 Eyes
Clear Bottle ReNu MultiPlus Multi-Purpose SolutionLens DepositsAbsent281 Eyes
Clear Bottle ReNu MultiPlus Multi-Purpose SolutionLens DepositsPresent19 Eyes
Primary

Slit Lamp Findings

Graded 0-4 where Grade 0=none; Grade 1=Trace; Grade 2=Mild; Grade 3=Moderate; Grade 4=Severe.

Time frame: Over-all follow-up visits from baseline to1 month

Population: Graded Slit Lamp Findings over All Follow-Up Visits (Any finding, All Dispensed Eyes, 151 + 2 possible).

ArmMeasureGroupValue (NUMBER)
Marketed Bottle ReNu MultiPlus Multi-Purpose SolutionSlit Lamp FindingsSlit Lamp Finding > Grade 21 Eyes
Marketed Bottle ReNu MultiPlus Multi-Purpose SolutionSlit Lamp FindingsSlit Lamp Findings </= Grade 2311 Eyes
Clear Bottle ReNu MultiPlus Multi-Purpose SolutionSlit Lamp FindingsSlit Lamp Finding > Grade 20 Eyes
Clear Bottle ReNu MultiPlus Multi-Purpose SolutionSlit Lamp FindingsSlit Lamp Findings </= Grade 2304 Eyes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026